← Back to Search

Behavioral Intervention

Brief pain exposure therapy (BPET) for Fibromyalgia (BPET Trial)

N/A

Recruiting

Led By John Sturgeon, PhD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Physician diagnosis of fibromyalgia (FM)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1, day 210

Awards & highlights

BPET Trial Summary

This trial aims to determine if a short online treatment using Zoom can assist adults with fibromyalgia in learning helpful methods for managing pain, disability, and other associated issues like depression or anxiety.

Who is the study for?

This trial is for adults with fibromyalgia, a condition causing widespread pain and tenderness. Participants should be comfortable using Zoom for therapy sessions aimed at reducing pain and related issues like disability, depression, or anxiety.Check my eligibility

What is being tested?

The study tests Brief Pain Exposure Therapy (BPET), a Zoom-based behavioral treatment designed to teach effective strategies for managing the symptoms of fibromyalgia.See study design

What are the potential side effects?

Since BPET is a type of psychological therapy delivered via Zoom, it does not have physical side effects like medications do. However, discussing painful experiences may cause temporary emotional discomfort.

BPET Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with fibromyalgia by a doctor.

BPET Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1, day 210

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1, day 210

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, day 210 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in pain intensity based on the Numeric Pain Rating Scale between day 1 (T1) and day 60 (T5)

Secondary outcome measures

Acceptability of intervention based on Mean scores on the Treatment Acceptability and Adherence Scale (TAAS)

Change in PROMIS Pain Interference from day 1 (T1) to day 210 (T8)

Change in TSK from day 1 (T1) to day 210 (T8)

+6 more

BPET Trial Design

1Treatment groups

Experimental Treatment

Group I: Brief pain exposure therapy (BPET)Experimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,798 Previous Clinical Trials

6,378,108 Total Patients Enrolled

15 Trials studying Fibromyalgia

1,491 Patients Enrolled for Fibromyalgia

John Sturgeon, PhDPrincipal InvestigatorUniversity of Michigan

1 Previous Clinical Trials

300 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to enroll in this ongoing clinical trial?

"As per information available on clinicaltrials.gov, this specific study is not actively recruiting participants. The trial was first posted on January 1st, 2024 and recently updated on January 16th, 2024. However, there are currently 101 other trials that are accepting patients at the moment."

Answered by AI